Ocugen OCGN Institutional Ownership

Ocugen, Inc. (NASDAQ:OCGN) is held by 150 institutional investors per 13F filings through June 2026.

• These investors collectively held 43.3% of Ocugen's outstanding shares in June 2026, up from 33.8% in March 2026.
• Their total shares held in OCGN increased 41.11% quarter over quarter, and separately, investors owning Ocugen increased 48.51% from a year ago.
• Of these 150 holders, 93 added to their stakes in Ocugen, 27 trimmed positions, and 30 made no changes.
• The aggregate institutional position in Ocugen amounted to 146.58Mn shares as of June 2026, up by 42.71Mn shares quarter on quarter, and up 94.42Mn shares year over year.
• BlackRock, Inc. holds the largest position in OCGN at 27.0Mn shares as of June 30, 2026, or 7.97% of shares outstanding.
• Top purchasers of OCGN stock for the quarter ending June 2026 included BlackRock, Inc. (19.7Mn), State Street Corp (11.8Mn), GEODE CAPITAL MANAGEMENT, LLC (4.64Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (2.39Mn), Northern Trust Corp (2.03Mn).
• The largest sellers of Ocugen for the quarter ending June 2026 were MARSHALL WACE, LLP (4.64Mn), UBS Group AG (2.1Mn), CITADEL ADVISORS LLC (2.03Mn), Qube Research & Technologies Ltd (1.57Mn), Virtu Financial LLC (382.93K).
• Ocugen's 10 largest shareholders as of June 2026 include BlackRock, Inc. (27.0Mn), State Street Corp (21.47Mn), VANGUARD CAPITAL MANAGEMENT LLC (14.37Mn), MILLENNIUM MANAGEMENT LLC (13.94Mn), GEODE CAPITAL MANAGEMENT, LLC (8.87Mn), RTW INVESTMENTS, LP (6.67Mn), UBS Group AG (5.18Mn), Ikarian Capital, LLC (3.96Mn), GMT CAPITAL CORP (3.51Mn), MARSHALL WACE, LLP (3.41Mn) per Business Quant data.